BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7940725)

  • 61. Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506.
    Przepiorka D; Abu-Elmagd K; Huaringa A; Luna M; van Besian K; Starzl TE; Fung JJ
    Bone Marrow Transplant; 1993 Jun; 11(6):502. PubMed ID: 7687503
    [No Abstract]   [Full Text] [Related]  

  • 62. Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD.
    Osumi T; Miharu M; Tanaka R; Du W; Takahashi T; Shimada H
    Bone Marrow Transplant; 2012 Jan; 47(1):139-40. PubMed ID: 21339748
    [No Abstract]   [Full Text] [Related]  

  • 63. Modified methotrexate regimen for prevention of graft-versus-host disease.
    Vowels M; Lam-Po-Tang R; Mameghan H; Ford D; Hughes DO
    Transplant Proc; 1986 Apr; 18(2):276-7. PubMed ID: 3515665
    [No Abstract]   [Full Text] [Related]  

  • 64. Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories.
    Sullivan KM; Shulman HM
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):51-62. PubMed ID: 2662536
    [No Abstract]   [Full Text] [Related]  

  • 65. [Intravenous placental immunoglobulin for treatment of chronic graft versus host disease].
    Zheng H; Lu DP; Guo NL
    Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):306-8. PubMed ID: 7835140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantation.
    Costello R; Blaise D; Jacquemier J; Monges G; Stoppa AM; Viens P; Olive D; Bouabdallah M; Brandely ; Gastaut JA
    Bone Marrow Transplant; 1995 Jul; 16(1):199-200. PubMed ID: 7581125
    [No Abstract]   [Full Text] [Related]  

  • 67. Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.
    Aschan J; Ringdén O; Tollemar J; Ljungman P; Lönnqvist B; Pihlstedt P; Markling L; Sundberg B
    Transplant Proc; 1990 Feb; 22(1):195-7. PubMed ID: 2309313
    [No Abstract]   [Full Text] [Related]  

  • 68. Indications for marrow transplantation in chronic myelogenous leukemia.
    Thomas ED; Clift RA
    Blood; 1989 Mar; 73(4):861-4. PubMed ID: 2645947
    [No Abstract]   [Full Text] [Related]  

  • 69. Images in clinical medicine. Oral lichen planus as a clinical sign of graft-versus-host disease.
    Findler M; Garfunkel AA
    N Engl J Med; 2003 Dec; 349(23):2223. PubMed ID: 14657429
    [No Abstract]   [Full Text] [Related]  

  • 70. Surgery for intestinal graft-versus-host disease: report of two cases.
    Evans J; Percy J; Eckstein R; Ma D; Schnitzler M
    Dis Colon Rectum; 1998 Dec; 41(12):1573-6. PubMed ID: 9860340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cyclosporine and graft-versus-host disease after bone marrow transplantation.
    N Engl J Med; 1988 Dec; 319(24):1607-8. PubMed ID: 3059188
    [No Abstract]   [Full Text] [Related]  

  • 72. Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2.
    Slavin S; Eckerstein A; Weiss L
    Nat Immun Cell Growth Regul; 1988; 7(3):180-4. PubMed ID: 3050476
    [No Abstract]   [Full Text] [Related]  

  • 73. Posterior segment complications of graft versus host disease after bone marrow transplantation.
    Strouthidis NG; Francis PJ; Stanford MR; Graham EM; Holder GE; Bird AC
    Br J Ophthalmol; 2003 Nov; 87(11):1421-3. PubMed ID: 14609847
    [No Abstract]   [Full Text] [Related]  

  • 74. Graft-versus-leukemia: no longer an epiphenomenon.
    Antin JH
    Blood; 1993 Oct; 82(8):2273-7. PubMed ID: 8400279
    [No Abstract]   [Full Text] [Related]  

  • 75. [Thrombotic thrombocytopenic purpura in bone marrow graft rejection (clin conference)].
    Pasquasy V; Delvenne P; Thiry A; Beguin Y; Boniver J
    Rev Med Liege; 1996 Nov; 51(11):714-7. PubMed ID: 9011925
    [No Abstract]   [Full Text] [Related]  

  • 76. Anticytoskeleton autoantibodies and chronic graft versus host disease.
    Gobbi M; Tazzari P; Tassinari A; Bandini G; Zauli D; Crespi C; Miserocchi F; Tura S
    Haematologica; 1985; 70(5):457-8. PubMed ID: 3937785
    [No Abstract]   [Full Text] [Related]  

  • 77. [Recent progress of bone marrow transplantation].
    Morishima Y; Saito H
    Nihon Rinsho; 1990 Jul; 48(7):1599-606. PubMed ID: 2205740
    [No Abstract]   [Full Text] [Related]  

  • 78. Chronic graft-versus-host disease and seizure.
    Azuno Y; Yaga K; Kaneko T; Kaku K; Oka Y
    Blood; 1998 Apr; 91(7):2626-8. PubMed ID: 9516171
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation.
    Kramer BS; Elfenbein GJ
    J Fla Med Assoc; 1984 May; 71(5):321-8. PubMed ID: 6429272
    [No Abstract]   [Full Text] [Related]  

  • 80. Vaginal stenosis with hematocolpometra, complicating chronic graft versus host disease.
    Anguenot JL; Ibéchéole V; Helg C; Piacenza JM; Dumps P; Bonnefoi H
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):185-7. PubMed ID: 12069746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.